Search

Artificial intelligence may soon play a critical role in choosing which depression therapy is best for patients.

Dr. Joseph Takahashi, noted for discovering the first gene controlling biological clocks in mammals, addressed the topic at the Society for Neuroscience annual meeting where he was awarded the Gruber Neuroscience Prize for his pioneering work in circadian rhythms.

A phase three clinical trial that UT Southwestern participated in determined that a three-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.

A new blood test for protein biomarkers could identify high risk heart patients.

UT Southwestern scientists have revealed that STING also activates a separate pathway, one that directly kills tumor-fighting immune cells.

Scientists have long known that the mucus membranes that line the intestines, lungs, and other sites play a key role in protecting the body from systemic infection.

Traditional cardiovascular risk factors, such as blood pressure, cholesterol levels, diabetes, and smoking status, are at least as valuable in predicting who will develop coronary heart disease as a sophisticated genetic test that surveys millions of different points in DNA.

Daylight saving is approaching again, perhaps for the penultimate time in some countries where a fierce debate is being waged over its impact on health and the economy.

Nearly 6,000 front-line health care workers at UT Southwestern have received initial doses of the COVID-19 vaccine since the Medical Center received its first shipment of 5,850 doses on Dec. 15.

Dr. Joseph Takahashi, who discovered the first circadian gene in mammals (CLOCK), points out that desynchronized body clocks are linked to greater health risks such as obesity, heart attack, cancer, and depression.